Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-063604
Filing Date
2020-12-15
Accepted
2020-12-15 19:10:36
Documents
2
Period of Report
2020-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7175
2 POA DOCUMENT poa.txt EX-24.4_950292 3868
  Complete submission text file 0001209191-20-063604.txt   12420
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Issuer) CIK: 0001662774 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CORTEXYME, INC. 269 EAST GRAND AVE. SOUTH SAN FRANCISCO CA 94080
Business Address
Detke Michael J. (Reporting) CIK: 0001770786 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38890 | Film No.: 201390838